Company profile
Advancing cell and gene therapies through powerful collaborations - Cell and Gene Therapy
Cell Therapy Catapult Services Limited is a UK company with status active founded in 2012 based in London.
Updated 06 Jun 2026 16:52
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
CS01 | Transaction MzQzNjAwMzA5MGFkaXF6a2N4
Published 16 Sep 2024 12:10
AA | Transaction MzQzNTI0NDU0M2FkaXF6a2N4 | Paper/PDF filed
Published 12 Sep 2024 06:12
Company registered at Companies House
1 Feb 2024 to 31 Jan 2026
The therapeutic potential for cell and gene therapies is immense, with treatments approved for previously intractable diseases. (e.g. Kymriah for blood cancers, Zolgensma for spinal muscular atrophy, and Luxturna for inherited retinal dystrophy) However, the price remains prohibitively high. Limiting patient access to relatively rare indications or narrow...
1 Mar 2020 to 30 Nov 2021
This project is aligned with the scope of the "Mechanising and Improving Advanced Therapy Manufacture" competition. Specifically, the project will address challenges in the manufacture of AAV gene therapies and will establish Allergan's UK-based 200-strong workforce as a key player within the AAV industry improving the competitiveness and productivity of ...
